Impact of pericardial fluid glucose level and computed tomography attenuation values on diagnosis of malignancy-related pericardial effusion

[1]  J. Alrahimi,et al.  Etiology of Pericardial Effusion and Outcomes Post Pericardiocentesis in the Western Region of Saudi Arabia: A Single-center Experience , 2020, Cureus.

[2]  A. Low,et al.  Causes and prognosis of symptomatic pericardial effusions treated by pericardiocentesis in an Asian academic medical centre. , 2020, Singapore medical journal.

[3]  Peter Y. Kim,et al.  Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors. , 2019, The American journal of cardiology.

[4]  W. Desmet,et al.  Etiology and Long‐Term Outcome of Patients Undergoing Pericardiocentesis , 2017, Journal of the American Heart Association.

[5]  D. Aras,et al.  Effectiveness of computed tomography attenuation values in characterization of pericardial effusion , 2017, Anatolian journal of cardiology.

[6]  W. William,et al.  Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. , 2015, Journal of the American College of Cardiology.

[7]  P. Charron,et al.  The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) , 2015 .

[8]  N. Çam,et al.  Differentiation between Transudate and Exudate in Pericardial Effusion has almost no Diagnostic Value in Contemporary Medicine. , 2015, Clinical laboratory.

[9]  M. LeWinter,et al.  Clinical practice. Acute pericarditis. , 2014, The New England journal of medicine.

[10]  T. Michiue,et al.  Postmortem virtual volumetry of the heart and lung in situ using CT data for investigating terminal cardiopulmonary pathophysiology in forensic autopsy. , 2014, Legal medicine.

[11]  I. Burazor,et al.  Malignant Pericardial Effusion , 2013, Cardiology.

[12]  B. Maisch,et al.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion , 2013, Heart Failure Reviews.

[13]  M. Desai,et al.  The Role of Multimodality Imaging in the Management of Pericardial Disease , 2010, Circulation. Cardiovascular imaging.

[14]  C. Roobottom,et al.  Imaging the pericardium: appearances on ECG-gated 64-detector row cardiac computed tomography. , 2010, The British journal of radiology.

[15]  Y. Adler,et al.  Controversial Issues in the Management of Pericardial Diseases , 2010, Circulation.

[16]  B. Mayosi.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa , 2007, Heart.

[17]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[18]  R. Rifkin,et al.  Noninvasive evaluation of pericardial effusion composition by computed tomography. , 2005, American heart journal.

[19]  J. Beckman,et al.  Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  K. Nandalur,et al.  Accuracy of computed tomography attenuation values in the characterization of pleural fluid: an ROC study. , 2005, Academic radiology.

[21]  A. Chetrit,et al.  The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. , 2005, The American journal of medicine.

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[23]  Adolfo García-Riego,et al.  Malignant Pericardial Effusion , 2001, Acta Cytologica.

[24]  T. Prendergast,et al.  The usefulness of diagnostic tests on pericardial fluid. , 1997, Chest.

[25]  K. Sullivan,et al.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.